19+
12
4
3
01

Phase III
02

ADCBispecific AntibodiesSmall Molecule
Team LeadershipPeople ManagementOrg Building
MRCTHematologyGynecologic Oncology
Biotech PartnershipFIHGlobal Integration
BCMA ADCICOSIO Therapy
Pre-INDINDRegulatory
NDACSRSLE
Medical AffairsKOLP5 Strategy
03

04

M.S.
📄
📝
📚
05

🏆
🎖️
🗣️
🥇